Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2

被引:312
作者
Unger, T
Juven-Gershon, T
Moallem, E
Berger, M
Sionov, RV
Lozano, G
Oren, M
Haupt, Y [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
[2] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
apoptosis; degradation; Mdm2; p53; phosphorylation;
D O I
10.1093/emboj/18.7.1805
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In response to environmental stress, the p53 phosphoprotein is stabilized and activated to inhibit cell growth. p53 stability and activity are negatively regulated by the murine double minute (Mdm2) oncoprotein in an autoregulatory feedback loop. The inhibitory effect of Mdm2 on p53 has to be tightly regulated for proper p53 activity, Phosphorylation is an important level of p53 regulation. In response to DNA damage, p53 is phosphorylated at several N-terminal serines, In this study we examined the role of Ser20, a potential phosphorylation site in human p53, in the regulation of p53 stability and function. Substitution of Ser20 by Ala (p53-Ala20) significantly increases the susceptibility of human p53 to negative regulation by Mdm2, in vivo, as measured by apoptosis and transcription activation assays. Mutation of Ser20 to Ala renders p53 less stable and more prone to Mdm2-mediated degradation. While the in vitro binding of p53 to Mdm2 is not increased by the Ala20 mutation, the same mutation results in a markedly enhanced binding in vivo, This is consistent with the conclusion that phosphorylation of Ser20 in vivo attenuates the binding of wild-type p53 to Mdm2. Peptides bearing nonphosphorylated Ser20 or Ala20 compete with p53 for Mdm2 binding, while a similar peptide with phosphorylated Ser20 does not. This implies a critical role for Ser20 in modulating the negative regulation of p53 by Mdm2, probably through phosphorylation-dependent inhibition of p53-Mdm2 interaction.
引用
收藏
页码:1805 / 1814
页数:10
相关论文
共 76 条
  • [11] Chen JD, 1996, MOL CELL BIOL, V16, P2445
  • [12] FEATURES OF APOPTOTIC CELLS MEASURED BY FLOW-CYTOMETRY
    DARZYNKIEWICZ, Z
    BRUNO, S
    DELBINO, G
    GORCZYCA, W
    HOTZ, MA
    LASSOTA, P
    TRAGANOS, F
    [J]. CYTOMETRY, 1992, 13 (08): : 795 - 808
  • [13] E1A signaling to p53 involves the p19ARF tumor suppressor
    de Stanchina, E
    McCurrach, ME
    Zindy, F
    Shieh, SY
    Ferbeyre, G
    Samuelson, AV
    Prives, C
    Roussel, MF
    Sherr, CJ
    Lowe, SW
    [J]. GENES & DEVELOPMENT, 1998, 12 (15) : 2434 - 2442
  • [14] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [15] FISCELLA M, 1994, ONCOGENE, V9, P3249
  • [16] JNK targets p53 ubiquitination and degradation in nonstressed cells
    Fuchs, SY
    Adler, V
    Buschmann, T
    Yin, ZM
    Wu, XW
    Jones, SN
    Ronai, Z
    [J]. GENES & DEVELOPMENT, 1998, 12 (17) : 2658 - 2663
  • [17] Stress-activated kinases regulate protein stability
    Fuchs, SY
    Fried, VA
    Ronai, Z
    [J]. ONCOGENE, 1998, 17 (11) : 1483 - 1490
  • [18] The complexity of p53 modulation: emerging patterns from divergent signals
    Giaccia, AJ
    Kastan, MB
    [J]. GENES & DEVELOPMENT, 1998, 12 (19) : 2973 - 2983
  • [19] p53 in growth control and neoplasia
    Gottlieb, TM
    Oren, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 77 - 102
  • [20] p300/MDM2 complexes participate in MDM2-mediated p53 degradation
    Grossman, SR
    Perez, M
    Kung, AL
    Joseph, M
    Mansur, C
    Xiao, ZX
    Kumar, S
    Howley, PM
    Livingston, DM
    [J]. MOLECULAR CELL, 1998, 2 (04) : 405 - 415